07:13 AM EDT, 10/30/2024 (MT Newswires) -- Zimmer Biomet Holdings ( ZBH ) reported Q3 adjusted earnings Wednesday of $1.74 per diluted share, up from $1.65 a year earlier.

Analysts polled by Capital IQ expected $1.74.

Net sales for the quarter ended Sept. 30 were $1.82 billion, up from $1.75 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.79 billion.

Zimmer Biomet ( ZBH ) said it now expects 2024 adjusted earnings of $7.95 to $8.05 per diluted share, compared with its prior guidance of $8.00 to $8.15. Analysts surveyed by Capital IQ expect $7.95.

The company said it now expects 2024 reported revenue growth of 3.5% to 4%, versus the previous estimate of 4% to 5%.